Latest / The Integrative Clinician by BridgeWell / Vitamins And Vibes?
Transcript
- 0:00Speaker: A physician I trained under used to call functional medicine vitamins and vibes.
- 0:05Speaker: And you know what?
- 0:06Speaker: There are days when I think he had a point.
- 0:09Speaker: I've seen patients taking 14 supplements, none of them clearly connected to an established diagnosis or measurable treatment goal.
- 0:17Speaker: I've seen expensive specialty laboratory panels ordered before anyone finished evaluating the patient's basic medical history.
- 0:24Speaker: And I've seen patients convinced that they have adrenal fatigue, multiple food sensitivities, or a collection of hormonal imbalances based on tests that have very little clinical validation.
- 0:36Speaker: But here's the thing.
- 0:37Speaker: I've also seen what happens when a nurse practitioner understands the underlying physiology, recognizes patterns that deserve further evaluation, and brings nutrition, lifestyle interventions, and individualized treatment into the clinical plan.
- 0:52Speaker: Those are two very different approaches.
- 0:55Speaker: And unfortunately, they're often grouped under the same label.
- 0:58Speaker: So today I want to talk about something that I think we need to discuss more openly in functional and integrative medicine.
- 1:05Speaker: What actually makes this approach worth practicing?
- 1:08Speaker: And how do we distinguish meaningful clinical care from expensive testing, supplement protocols, and a lot of very confident marketing?
- 1:15Speaker: Because if we're going to ask our patients to trust us, we need to be able to defend what we're doing.
- 1:21Speaker: Welcome to the Integrative Clinician, the podcast from Bridgewell Integrative Education.
- 1:26Speaker: I'm Dr.
- 1:27Speaker: Sheri Erwin, a nurse practitioner, educator, and founder of Bridgewell.
- 1:32Speaker: I've spent more than 30 years in healthcare, including years in conventional clinical practice, advanced practice nursing, and nursing education.
- 1:40Speaker: And over time, one of the things that became increasingly important to me was understanding not just what we do for patients, but why we do it.
- 1:48Speaker: Why does one patient develop insulin resistance while another doesn't?
- 1:52Speaker: Why do two women with similar thyroid laboratory results have completely different symptoms?
- 1:57Speaker: Why does one patient respond well to a particular treatment while another patient seems to make very little progress?
- 2:04Speaker: And what do we do with the patient who doesn't fit neatly into one diagnosis?
- 2:08Speaker: Those are some of the questions that led me deeper into functional and integrative medicine.
- 2:13Speaker: But the longer I've worked in this field, the more convinced I've become that we have to be careful about how we practice it.
- 2:20Speaker: Because I don't believe functional medicine is automatically better medicine.
- 2:24Speaker: I believe it gives us a framework for asking broader clinical questions.
- 2:27Speaker: Whether those questions lead to better care depends on how well we understand the physiology, evaluate the evidence, and apply what we know.
- 2:36Speaker: And that's what we're going to explore today.
- 2:38Speaker: Let's go back to that physician I mentioned.
- 2:40Speaker: He had encountered a patient who was taking 14 different supplements after receiving care from a functional medicine practitioner.
- 2:47Speaker: Now, I don't know that every supplement was inappropriate.
- 2:50Speaker: There are legitimate reasons to use nutritional supplementation.
- 2:54Speaker: We treat deficiencies.
- 2:56Speaker: We address specific clinical indications.
- 2:59Speaker: And sometimes we have evidence supporting a particular supplement in a defined patient population.
- 3:04Speaker: But 14 supplements should make us stop and ask some questions.
- 3:08Speaker: Why is the patient taking each one?
- 3:11Speaker: What specific clinical problem are we treating?
- 3:13Speaker: What's the evidence that the supplement will improve that problem?
- 3:16Speaker: Are there potential interactions?
- 3:18Speaker: And perhaps most importantly, how are we going to know whether it's working?
- 3:22Speaker: Because recommending a supplement is a clinical intervention.
- 3:26Speaker: It's not somehow exempt from clinical scrutiny because it doesn't require a prescription.
- 3:30Speaker: I think one of the mistakes we sometimes make in integrative medicine is assuming that because something is natural, it's automatically appropriate.
- 3:39Speaker: But natural products can have pharmacologic effects.
- 3:42Speaker: They can alter drug metabolism, they can affect blood pressure, glucose regulation, bleeding risk, or liver function.
- 3:50Speaker: And the quality and composition of commercially available supplements can vary.
- 3:54Speaker: St.
- 3:54Speaker: John's wort is a familiar example.
- 3:56Speaker: It can induce drug metabolizing enzymes and transporters, creating clinically important interactions with medications, including some immunosuppressants and hormonal contraceptives.
- 4:07Speaker: That's not a theoretical concern.
- 4:09Speaker: That's something an NP needs to understand before making a recommendation.
- 4:13Speaker: So when I hear someone describe integrative medicine as mostly supplements, I think part of the problem is that we've allowed supplements to become the most visible part of the field.
- 4:22Speaker: They're easy to market, they're easy to sell, and they're easy to turn into protocols.
- 4:27Speaker: But they are not the foundation of good integrative care.
- 4:31Speaker: The foundation should be the patient's physiology, clinical presentation, risk factors, and the best available evidence.
- 4:38Speaker: Let's consider another example.
- 4:40Speaker: Adrenal fatigue.
- 4:42Speaker: How many patients have you seen who have been told that their adrenal glands are exhausted?
- 4:47Speaker: They describe fatigue, poor sleep, difficulty concentrating, and feeling overwhelmed.
- 4:53Speaker: Those symptoms absolutely deserve attention.
- 4:56Speaker: But adrenal fatigue is not an established endocrine diagnosis.
- 5:00Speaker: That distinction matters.
- 5:02Speaker: Because when we label a patient with an unsupported diagnosis, we can inadvertently stop looking for the real explanation.
- 5:08Speaker: Maybe the patient has obstructive sleep apnea.
- 5:11Speaker: Maybe they're experiencing significant depression or another behavioral health condition.
- 5:16Speaker: Maybe their medication is contributing to the fatigue.
- 5:19Speaker: Maybe they're dealing with iron deficiency, thyroid dysfunction, chronic illness, or simply prolonged sleep deprivation.
- 5:26Speaker: There are many possibilities.
- 5:28Speaker: And there are also legitimate ways to evaluate the hypothalamic pituitary adrenal axis when the presentation supports that investigation.
- 5:36Speaker: But we shouldn't confuse a valid physiologic system with a diagnosis that hasn't been established.
- 5:42Speaker: The same concern comes up with food sensitivity testing.
- 5:45Speaker: Commercial food IgG panels are widely marketed, but food-specific IgG testing has not been validated for diagnosing food allergies or intolerances.
- 5:55Speaker: In fact, IgG may reflect normal exposure or tolerance.
- 5:59Speaker: Imagine a patient who has chronic bloating and is told to eliminate 20 different foods based on one of these panels.
- 6:06Speaker: Now that patient is worried about everything they eat.
- 6:09Speaker: They're spending more money.
- 6:11Speaker: Their diet is becoming increasingly restrictive, and we still haven't established why they're experiencing bloating.
- 6:18Speaker: Maybe they have celiac disease, lactose intolerance, constipation, irritable bowel syndrome, or something else.
- 6:25Speaker: That doesn't mean dietary interventions can't help.
- 6:29Speaker: They often can when they're appropriately selected and monitored, but we need a defensible reason for choosing the intervention.
- 6:36Speaker: And that's where I believe our clinical reasoning becomes so important.
- 6:40Speaker: The problem isn't that functional medicine asks different questions.
- 6:44Speaker: The problem is when we accept answers that haven't been adequately tested.
- 6:48Speaker: Now let's talk about the other side of this, because I also think some clinicians dismiss integrative medicine without recognizing how much meaningful evidence exists for interventions that address nutrition, physical activity, metabolic health, and other determinants of disease.
- 7:05Speaker: One of my favorite examples is the diabetes prevention program.
- 7:09Speaker: If you've been in healthcare for any length of time, you're probably familiar with this research.
- 7:14Speaker: More than 3,000 adults at elevated risk for developing type 2 diabetes participated in the original randomized trial.
- 7:22Speaker: The researchers compared an intensive lifestyle intervention, metformin, and placebo, and the results were significant.
- 7:29Speaker: The structured lifestyle intervention reduced the incidence of type 2 diabetes by approximately 58% compared with placebo.
- 7:36Speaker: Metformin reduced incidence by approximately 31%.
- 7:40Speaker: Now, I want to be precise about what this study tells us.
- 7:44Speaker: It doesn't prove that lifestyle medicine is always better than medication, and it doesn't justify withholding medication from someone who needs it.
- 7:51Speaker: It demonstrates that a structured, well-supported lifestyle intervention can produce clinically meaningful outcomes in an appropriately selected population.
- 8:00Speaker: And look at what that intervention involved.
- 8:03Speaker: It wasn't somebody handing the patient a sheet of dietary recommendations and telling them to try harder.
- 8:09Speaker: It involved education, coaching, physical activity goals, dietary changes, and ongoing support.
- 8:16Speaker: The Lifestyle ARM targeted approximately 7% weight loss and at least 150 minutes of moderate physical activity per week.
- 8:24Speaker: There was a systematic approach.
- 8:26Speaker: And that is what I think we need to emphasize.
- 8:29Speaker: Lifestyle medicine is not simply giving patients more advice.
- 8:33Speaker: It's understanding what changes are likely to improve their health, determining whether those changes are realistic, and helping patients implement and sustain them.
- 8:42Speaker: Consider the patient with prediabetes.
- 8:45Speaker: We can prescribe medication when indicated.
- 8:47Speaker: We can also look at their dietary pattern, activity level, sleep, weight trajectory, medication exposures, and barriers to behavior change.
- 8:56Speaker: Those are not competing strategies.
- 8:58Speaker: They're complementary pieces of care.
- 9:00Speaker: And sometimes we have to address those factors before our treatment plan is going to work as well as we expect.
- 9:06Speaker: Another example is the Mediterranean dietary pattern.
- 9:09Speaker: Research, including the Predamid trial, has demonstrated cardiovascular benefits associated with Mediterranean dietary interventions.
- 9:17Speaker: The Predim study required reanalysis because of problems with the original randomization procedures, and that limitation deserves acknowledgement.
- 9:25Speaker: But it remains part of a larger body of evidence supporting dietary patterns that emphasize vegetables, fruits, legumes, whole grains, nuts, olive oil, and other minimally processed foods.
- 9:37Speaker: There's a reason nutrition matters in cardiometabolic care.
- 9:40Speaker: It affects far more than calories.
- 9:42Speaker: Dietary patterns can influence lipid concentrations, glycemic control, blood pressure, and other cardiovascular risk factors.
- 9:50Speaker: When we understand that physiology, we're better equipped to make specific recommendations rather than simply telling patients to eat healthier.
- 9:58Speaker: And that brings me to something important.
- 10:00Speaker: A strong evidence-based approach does not mean we abandon the integrative perspective.
- 10:06Speaker: It means we become more thoughtful about which interventions deserve to be part of that perspective.
- 10:12Speaker: Because evidence also tells us when something doesn't work as well as we hoped.
- 10:16Speaker: Take vitamin D.
- 10:17Speaker: For years, vitamin D was promoted as a way to reduce all sorts of chronic diseases.
- 10:22Speaker: And there are legitimate reasons to assess and treat vitamin D deficiency in appropriate clinical circumstances.
- 10:29Speaker: But the vital trial, which included more than 25,000 participants, did not find a significant reduction in the primary outcomes of invasive cancer or major cardiovascular events with routine vitamin D supplementation.
- 10:43Speaker: That doesn't make vitamin D useless.
- 10:45Speaker: It tells us that correcting deficiency and giving supplements broadly to prevent disease are two different clinical questions.
- 10:52Speaker: As integrative clinicians, we should be comfortable with both kinds of findings.
- 10:57Speaker: The studies that support interventions we use and the studies that challenge them.
- 11:01Speaker: Because the goal isn't to defend every treatment associated with integrative medicine.
- 11:06Speaker: The goal is to improve patient outcomes.
- 11:09Speaker: Let's put some of this into a clinical example.
- 11:12Speaker: I want you to imagine a 47-year-old woman who comes into your office complaining of fatigue, weight gain, difficulty concentrating, and poor sleep.
- 11:21Speaker: She's frustrated.
- 11:22Speaker: She's already been evaluated elsewhere.
- 11:24Speaker: Her CBC is normal.
- 11:26Speaker: Her metabolic panel is unremarkable.
- 11:28Speaker: Her fasting glucose is 94.
- 11:31Speaker: Her TSH is 3.8.
- 11:33Speaker: Her serum B12 is 300.
- 11:36Speaker: And she's been told that everything looks fine.
- 11:38Speaker: She doesn't feel fine.
- 11:39Speaker: So what do we do?
- 11:40Speaker: I'm using a hypothetical patient here, but this is the kind of presentation many of us encounter regularly.
- 11:46Speaker: And I want you to pay attention to how we approach it.
- 11:49Speaker: Because a functional and integrative assessment should not begin by deciding that all of those laboratory results are abnormal.
- 11:56Speaker: It should begin by asking what we know and what we still need to understand.
- 12:00Speaker: First, let's consider her fatigue.
- 12:02Speaker: When did it begin?
- 12:03Speaker: Was the onset gradual or sudden?
- 12:06Speaker: Is it constant or does it fluctuate throughout the day?
- 12:09Speaker: What does her sleep actually look like?
- 12:11Speaker: Does she snore?
- 12:12Speaker: Does she wake feeling unrefreshed?
- 12:14Speaker: What medications or supplements is she taking?
- 12:17Speaker: Has her menstrual cycle changed?
- 12:19Speaker: Does she have heavy bleeding?
- 12:21Speaker: Has she noticed hot flashes or night sweats?
- 12:23Speaker: Is she experiencing symptoms of depression or anxiety?
- 12:27Speaker: And are there any concerning findings that would require a more urgent evaluation?
- 12:32Speaker: These questions sound basic, but that's exactly the point.
- 12:36Speaker: Sometimes we become so focused on finding an advanced explanation that we overlook the most useful information in the history.
- 12:44Speaker: Now let's look at the thyroid.
- 12:46Speaker: Her TSH is 3.8.
- 12:49Speaker: Depending on the laboratory, that's probably within the reference range.
- 12:53Speaker: And here's where we have to be careful.
- 12:55Speaker: There is ongoing discussion about thyroid reference intervals, the distribution of TSH in healthy populations, and the role of thyroid autoimmunity.
- 13:04Speaker: But a TSH of 3.8 does not by itself establish hypothyroidism, and it doesn't mean the patient automatically needs thyroid hormone.
- 13:15Speaker: What matters is the rest of the clinical picture.
- 13:17Speaker: Does she have a personal or family history of autoimmune thyroid disease?
- 13:22Speaker: Does she have a goiter?
- 13:23Speaker: What does her free T4 show if further evaluation is clinically indicated?
- 13:28Speaker: Are there symptoms or findings that increase our suspicion?
- 13:32Speaker: And what do we know about the trend in her laboratory results?
- 13:36Speaker: The answers may lead us toward additional evaluation, or they may lead us away from a thyroid explanation entirely.
- 13:43Speaker: Both are examples of clinical reasoning.
- 13:46Speaker: We're not trying to turn every patient into a thyroid patient.
- 13:50Speaker: We're trying to understand whether thyroid disease is actually contributing to the presentation.
- 13:55Speaker: Now let's consider the fasting glucose of 94.
- 13:59Speaker: That's normal.
- 14:00Speaker: But we know that glucose regulation is more complicated than a single fasting measurement.
- 14:06Speaker: In some individuals, insulin resistance and compensatory changes in insulin secretion develop before fasting glucose rises.
- 14:14Speaker: That's legitimate physiology.
- 14:16Speaker: However, that does not mean fasting insulin is a universally validated screening test or that every patient with a normal glucose needs an insulin level.
- 14:26Speaker: We should distinguish between a physiologic relationship and a clinically validated diagnostic strategy.
- 14:32Speaker: So what else should we evaluate?
- 14:34Speaker: Her A1C when indicated, her blood pressure, her lipid profile, her weight and waist circumference, her history of gestational diabetes, her family history, her overall metabolic risk, and of course the dietary and physical activity patterns that may be contributing.
- 14:52Speaker: The point is not to collect every possible metabolic marker.
- 14:55Speaker: It's to determine whether she's developing clinically important risk that deserves intervention.
- 15:00Speaker: And here's something that I think gets lost in the discussion about functional medicine.
- 15:05Speaker: We don't always need to establish a new diagnosis before we can make a meaningful difference.
- 15:09Speaker: If a patient has poor sleep, low physical activity, increasing central adiposity, and other cardiometabolic risk factors.
- 15:17Speaker: We have evidence-based interventions worth discussing.
- 15:21Speaker: We can address those factors without inventing a disease.
- 15:25Speaker: Now let's look at her B12.
- 15:27Speaker: Her serum B12 is 300.
- 15:29Speaker: This one deserves a closer look.
- 15:31Speaker: NICE guidance identifies total B12 values between 180 and 350 picograms per milliliter as an indeterminate range where deficiency may be possible.
- 15:42Speaker: So, unlike the normal fasting glucose, this result has a specific diagnostic interpretation that could justify further evaluation.
- 15:50Speaker: But again, context matters.
- 15:52Speaker: Does she have paresthesis?
- 15:54Speaker: Difficulty with balance?
- 15:56Speaker: Cognitive symptoms?
- 15:57Speaker: A restricted dietary pattern?
- 15:59Speaker: A history of gastrointestinal disease or surgery.
- 16:03Speaker: Is she taking metformin or a proton pump inhibitor?
- 16:06Speaker: If the presentation raises concern for B12 deficiency, methylmalonic acid may help clarify the diagnosis.
- 16:13Speaker: And in certain higher risk situations, treatment should not be delayed simply while waiting for confirmatory testing.
- 16:20Speaker: That is a very different approach from saying everybody needs to keep their B12 above an arbitrary optimal number.
- 16:26Speaker: We're using the patient's presentation and published diagnostic guidance to determine what to do next.
- 16:32Speaker: And that's the skill I want nurse practitioners to develop.
- 16:35Speaker: Not memorizing a list of optimal laboratory ranges, understanding what a result means, what it doesn't mean, and what additional information would actually change management.
- 16:45Speaker: Now there's one more piece of this patient's story.
- 16:47Speaker: She's 47.
- 16:49Speaker: And when we ask about her menstrual history, we discover that her cycles have become irregular.
- 16:54Speaker: She's waking up several nights a week feeling hot.
- 16:57Speaker: She's more irritable.
- 16:59Speaker: And she says her concentration is worse on the days after she slept poorly.
- 17:03Speaker: Could paramenopause be contributing?
- 17:05Speaker: Absolutely.
- 17:06Speaker: That doesn't prove it's the only explanation for her symptoms, but it should be part of our assessment.
- 17:12Speaker: And in a woman in the typical age range with a characteristic clinical presentation, we often don't need an extensive hormone panel to recognize the menopause transition.
- 17:23Speaker: We need a good history, a careful evaluation of competing explanations, and an understanding of when testing adds value.
- 17:31Speaker: That's how these clinical pieces begin to connect.
- 17:34Speaker: We have sleep.
- 17:35Speaker: We have menopausal symptoms, we have metabolic risk, we have a potentially indeterminate B12 result, and we have thyroid findings that need to be interpreted rather than automatically treated.
- 17:48Speaker: Those are not necessarily four separate diagnoses requiring four separate protocols.
- 17:53Speaker: They're clinical questions that need to be prioritized, and the treatment plan should reflect what we actually establish.
- 18:00Speaker: Now let's take this one step further.
- 18:03Speaker: Suppose our patient has been reading about functional medicine.
- 18:06Speaker: She asks you to order a comprehensive hormone panel, an advanced microbiome test, food sensitivity testing, and a cortisol panel.
- 18:14Speaker: She believes those tests will finally explain why she feels so poorly.
- 18:19Speaker: What do you do?
- 18:20Speaker: I think this is where the distinction between testing and clinical reasoning becomes especially important.
- 18:25Speaker: Before I order any test, I want to ask three questions.
- 18:29Speaker: First, what clinical question am I trying to answer?
- 18:33Speaker: Second, is the test valid for answering that question?
- 18:36Speaker: And third, what will I do differently based on the result?
- 18:39Speaker: Those sound like simple questions.
- 18:42Speaker: But they can dramatically change how we practice.
- 18:45Speaker: Let's consider the microbiome panel.
- 18:48Speaker: The relationship between the intestinal microbiome and human health is a fascinating area of research.
- 18:54Speaker: There is strong evidence that microbial communities are involved in digestion, immune function, and various metabolic processes.
- 19:02Speaker: But that does not establish the clinical utility of every commercially available stool microbiome panel.
- 19:08Speaker: A test may identify differences in bacterial abundance without demonstrating that the reported pattern is an established cause of the patient's symptoms.
- 19:17Speaker: And even if the test accurately measures a particular organism, we still need to know whether acting on that finding improves patient outcomes.
- 19:26Speaker: That's a different question.
- 19:27Speaker: If the patient has persistent diarrhea, weight loss, gastrointestinal bleeding, or another concerning finding, we need an appropriate medical evaluation.
- 19:37Speaker: If she has bloating or altered bowel habits, our assessment should reflect the history, examination, alarm features, and relevant diagnostic criteria.
- 19:46Speaker: We shouldn't automatically substitute a commercial microbiome report for that process.
- 19:51Speaker: Now, there are validated stool tests with very specific clinical uses.
- 19:56Speaker: Testing for certain infections, inflammatory markers in appropriate circumstances, and other established indications can be valuable.
- 20:03Speaker: The distinction isn't conventional testing versus functional testing.
- 20:07Speaker: It's whether the test has demonstrated usefulness for the question we're asking.
- 20:11Speaker: The same principle applies to hormone testing.
- 20:14Speaker: There are times when hormone measurement is essential, and there are times when a broad panel may add cost and confusion without changing the clinical plan.
- 20:23Speaker: For a woman in perimenopause, hormonal fluctuation can make a single measurement difficult to interpret.
- 20:29Speaker: A beautifully formatted laboratory report doesn't eliminate that biological variability.
- 20:34Speaker: We need to understand what the test measures, how reliable it is, and whether the result can support the treatment decision we're considering.
- 20:42Speaker: And that's really what I mean when I talk about evidence-informed integrative care.
- 20:47Speaker: It's not simply knowing which laboratory company offers which panel.
- 20:51Speaker: It's knowing when that panel is useful, when it's unnecessary, and when it may lead us in the wrong direction.
- 20:57Speaker: I think that's a much higher level of clinical skill.
- 21:01Speaker: And it's one that we should be teaching intentionally.
- 21:03Speaker: Here's another area where I think we need to challenge ourselves.
- 21:06Speaker: We talk a lot about individualized care in functional medicine.
- 21:10Speaker: But sometimes what gets called individualized care is really a collection of standard protocols assigned to patients based on a few symptoms or laboratory values.
- 21:21Speaker: Fatigue.
- 21:22Speaker: Here's the adrenal protocol.
- 21:24Speaker: Bloating.
- 21:25Speaker: Here's the gut protocol, weight gain, here's the insulin resistance protocol.
- 21:30Speaker: Now, protocols can be useful.
- 21:32Speaker: They can provide structure, improve consistency, and help us remember important steps.
- 21:37Speaker: But a protocol is not a substitute for clinical judgment.
- 21:40Speaker: Let's go back to our patient.
- 21:42Speaker: Suppose she has poor sleep because she's waking several times a night with vasomotor symptoms.
- 21:47Speaker: Would an adrenal supplement protocol address that problem?
- 21:50Speaker: Not necessarily.
- 21:52Speaker: Would ordering a large stool panel help us decide how to manage those symptoms?
- 21:57Speaker: Probably not.
- 21:58Speaker: But evaluating the Menopause transition, discussing appropriate treatment options, addressing sleep, and considering other causes of fatigue might.
- 22:07Speaker: Or suppose her fatigue is related to clinically significant B12 deficiency.
- 22:12Speaker: The appropriate treatment depends on the cause, severity, neurologic findings, and potential problems with absorption.
- 22:19Speaker: That is not the same as recommending a general energy supplement.
- 22:22Speaker: Or suppose she has obstructive sleep apnea.
- 22:25Speaker: No supplement combination should delay appropriate assessment and treatment for that condition.
- 22:30Speaker: This is what individualized medicine should mean.
- 22:33Speaker: We're not just selecting different products for different patients.
- 22:36Speaker: We're identifying the most important contributors to the presentation and choosing interventions that address those contributors.
- 22:44Speaker: And we're reassessing.
- 22:45Speaker: If we make a recommendation, we need to decide what success looks like.
- 22:49Speaker: What symptoms should improve?
- 22:51Speaker: What measurable clinical outcome are we following?
- 22:54Speaker: When should we expect a response?
- 22:56Speaker: What adverse effects are we watching for?
- 22:59Speaker: And what will we do if the treatment doesn't work?
- 23:02Speaker: These are questions that should guide supplement recommendations, nutrition interventions, medications, and every other part of the treatment plan.
- 23:09Speaker: Because a treatment without a clear objective becomes difficult to evaluate.
- 23:14Speaker: And if we can't evaluate it, how do we know whether we're helping?
- 23:17Speaker: There's one more misconception I want to address.
- 23:20Speaker: I hear from nurse practitioners who are interested in functional and integrative medicine, but they assume they can't use any of it unless they leave their current job and open a cash-based practice.
- 23:32Speaker: And that simply isn't true.
- 23:33Speaker: You can begin applying integrative clinical reasoning in the setting where you already practice.
- 23:39Speaker: You can improve the quality of your history taking.
- 23:41Speaker: You can recognize patterns in metabolic health.
- 23:44Speaker: You can incorporate evidence-based nutrition and lifestyle interventions.
- 23:49Speaker: You can interpret laboratory results with greater attention to the patient's clinical presentation.
- 23:54Speaker: You can identify when additional evaluation is warranted, and you can build a longitudinal plan that addresses risk factors alongside established disease.
- 24:04Speaker: Does that mean you can accomplish everything in 15 minutes?
- 24:07Speaker: Of course not.
- 24:08Speaker: I've worked in those settings and I know the limitations, but good care doesn't have to happen in one enormous visit.
- 24:15Speaker: Sometimes the first visit identifies the most important clinical question.
- 24:20Speaker: The second visit reviews the results and begins treatment.
- 24:23Speaker: The next visit evaluates response.
- 24:26Speaker: And over time, you build a better understanding of the patient's health.
- 24:31Speaker: That's not a radical departure from primary care.
- 24:34Speaker: It's thoughtful longitudinal medicine.
- 24:36Speaker: Now, if you eventually decide to build a practice that offers longer visits, additional education, or services that aren't covered by insurance, that's a different business decision.
- 24:47Speaker: And there may be good reasons to do that.
- 24:50Speaker: But it shouldn't be a prerequisite for learning integrative medicine.
- 24:53Speaker: I don't want nurse practitioners to believe they have to completely reinvent their careers before they can start using these skills.
- 25:00Speaker: I want them to recognize how much they can do within their existing roles while respecting their state scope of practice, clinical competencies, employer policies, and standards of care.
- 25:12Speaker: Because learning to think differently about a patient is something you can begin doing long before you change your practice model.
- 25:18Speaker: Now I want to come back to the original question.
- 25:21Speaker: What separates meaningful integrative care from vitamins and vibes?
- 25:26Speaker: I think it comes down to clinical discipline.
- 25:28Speaker: Can you explain the physiologic basis for what you're recommending?
- 25:31Speaker: Can you distinguish a plausible mechanism from a demonstrated clinical benefit?
- 25:36Speaker: Do you understand the quality and limitations of the evidence?
- 25:39Speaker: Can you recognize when a laboratory finding is interesting but not necessarily actionable?
- 25:44Speaker: Can you identify when a conventional diagnostic or treatment pathway is the most appropriate option?
- 25:50Speaker: And are you willing to change your approach when new evidence tells you something different?
- 25:55Speaker: Those are the questions I think should define our profession.
- 25:58Speaker: Not the number of specialty tests we can interpret, not the number of supplements we know how to recommend, and certainly not how many protocols we've collected.
- 26:07Speaker: Clinical confidence should come from understanding the reasoning behind our decisions.
- 26:12Speaker: I remember being early in my own integrative education and wanting to understand how everything connected.
- 26:19Speaker: The relationships between metabolic regulation, hormones, inflammation, nutrition, sleep, and chronic disease were fascinating to me.
- 26:27Speaker: And they still are.
- 26:29Speaker: But learning about those relationships is only the beginning.
- 26:32Speaker: We also have to learn which relationships are clinically established, which are still being investigated, and which have not yet demonstrated that changing them improves patient outcomes.
- 26:42Speaker: That's where education matters.
- 26:45Speaker: Because it's easy to find a weekend course that gives you a new protocol, it's much harder to find education that explains the physiology, examines the evidence, walks you through the clinical decisions, and teaches you how to apply that knowledge to patients who don't fit the textbook example.
- 27:02Speaker: And that's the reason I built Bridgewell Integrative Education.
- 27:05Speaker: I wanted nurse practitioners to have a place to learn functional and integrative medicine with the clinical depth they deserve, not simply what to order, not simply which supplement to recommend, but why a particular approach makes sense, what the evidence supports, and when a different clinical decision will be more appropriate.
- 27:24Speaker: That's also why our education includes clinical cases, because you can learn a great deal from studying physiology.
- 27:32Speaker: But the real challenge comes when you have a patient sitting in front of you with overlapping symptoms, imperfect laboratory results, multiple medications, and several possible explanations.
- 27:42Speaker: That's when you have to put the pieces together, and that's what I want our learners to be able to do.
- 27:47Speaker: So let's come back one last time to that physician who called functional medicine vitamins and vibins and vibes.
- 27:53Speaker: I understand why he said it.
- 27:55Speaker: And I think those of us who practice and teach integrative medicine should be willing to acknowledge the things that have contributed to that perception.
- 28:02Speaker: But I also think it would be a mistake to let the least credible parts of the field define the whole thing.
- 28:08Speaker: There is meaningful evidence supporting many interventions that are central to a comprehensive integrative approach.
- 28:14Speaker: There are important physiologic relationships that deserve our attention.
- 28:18Speaker: And there are patients who benefit when clinicians take the time to evaluate how their symptoms, medical history, risk factors, and treatment options fit together.
- 28:28Speaker: But none of that gives us permission to abandon scientific standards.
- 28:32Speaker: In fact, I believe the more we want to individualize care, the more important clinical reasoning becomes.
- 28:38Speaker: Because individualized care requires judgment.
- 28:42Speaker: It requires knowing what to investigate, what to treat, what to monitor, and sometimes what to leave alone.
- 28:49Speaker: And if you're a nurse practitioner who wants to develop those skills, that's exactly what we teach at Bridgewell.
- 28:54Speaker: Our Bridgewell Transformation Pathway brings together the foundational science and clinical applications of functional and integrative medicine with an emphasis on evidence, physiologic understanding, and real patient care.
- 29:06Speaker: You don't need to leave your current practice to begin learning.
- 29:10Speaker: And you don't need to choose between being a conventional nurse practitioner and an integrative clinician.
- 29:15Speaker: You can take the best of both approaches and learn how to apply them responsibly.
- 29:20Speaker: You can explore the Bridgewell Transformation Pathway and our individual courses at Bridgeweld.com.
- 29:25Speaker: I also run a free live case session where I take one real patient and walk through this kind of reasoning from start to finish, the history, the labs, and the decisions out loud and in real time.
- 29:37Speaker: If you want to see what we talked about today applied to an actual patient, the details and the link to events are in the show notes.
- 29:45Speaker: I'll also include the link to our blog articles, which include the blog that inspired today's episode, Vitamins and Vibes, The Functional Medicine Worth Your Time is the part nobody markets.
- 29:56Speaker: And I want to leave you with one question to consider in your own practice.
- 30:01Speaker: The next time you're thinking about ordering a specialty test, recommending a supplement, or using a particular protocol, ask yourself, how will this change my patient's care and what evidence suggests that change is likely to help?
- 30:14Speaker: If you can answer that question clearly, you're moving in the right direction.
- 30:18Speaker: And if you can't, that's an opportunity to learn more before you act.
- 30:22Speaker: Next time on the Integrative Clinician, we'll look at a patient already on thyroid treatment whose labs look appropriate but who still isn't well.
- 30:29Speaker: When the thyroid isn't the whole story, and how to reason through it without either dismissing her or reaching for T3 too soon.